Request Sample Inquiry
Vaccine Contract Manufacturing Market

Vaccine Contract Manufacturing Market

Vaccine Contract Manufacturing Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

142

Base Year:

2022

Date

Sep - 2023

Format:

PDF XLS PPT

Report Code:

VMR-2269

Segments Covered
  • By Vaccine Type By Vaccine Type Live Attenuated Vaccines , Conjugate Vaccines, Subunit Subunit Vaccines, Inactivated Vaccines, Recombinant Vector Vaccines, Toxoid Vaccines, Synthetic Vaccines
  • By Service Type By Service Type Fill-Finish, Bulk Product
  • By Product Type By Product Type Single Vaccine, Combination Vaccine
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 3.1 Billion
Revenue 2030Revenue 2030: USD 7.4 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 11.5%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Vaccine Contract Manufacturing Market - Segment Analysis
    1. Overview
    2. Global Vaccine Contract Manufacturing Market, 2016 - 2028 (USD Million)
    3. Global Vaccine Contract Manufacturing Market - by Vaccine Type
      1. By Live Attenuated Vaccines
      2. By Conjugate Vaccines
      3. By Subunit Subunit Vaccines
      4. By Inactivated Vaccines
      5. By Recombinant Vector Vaccines
      6. By Toxoid Vaccines
      7. By Synthetic Vaccines
    4. Global Vaccine Contract Manufacturing Market - by Service Type
      1. By Fill-Finish
      2. By Bulk Product
    5. Global Vaccine Contract Manufacturing Market - by Product Type
      1. By Single Vaccine
      2. By Combination Vaccine
    6. Global Vaccine Contract Manufacturing Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Vaccine Contract Manufacturing Market - Segment Analysis
    1. Overview
    2. North America Vaccine Contract Manufacturing Market, 2016 - 2028 (USD Million)
    3. North America Vaccine Contract Manufacturing Market, by Vaccine Type
      1. By Live Attenuated Vaccines
      2. By Conjugate Vaccines
      3. By Subunit Subunit Vaccines
      4. By Inactivated Vaccines
      5. By Recombinant Vector Vaccines
      6. By Toxoid Vaccines
      7. By Synthetic Vaccines
    4. North America Vaccine Contract Manufacturing Market, by Service Type
      1. By Fill-Finish
      2. By Bulk Product
    5. North America Vaccine Contract Manufacturing Market, by Product Type
      1. By Single Vaccine
      2. By Combination Vaccine
    6. North America Vaccine Contract Manufacturing Market, by Country
      1. U.S.
        1. U.S. Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. U.S. Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. U.S. Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      2. Canada
        1. Canada Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. Canada Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. Canada Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      3. Mexico
        1. Mexico Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. Mexico Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. Mexico Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
  5. Europe Vaccine Contract Manufacturing Market - Segment Analysis
    1. Overview
    2. Europe Vaccine Contract Manufacturing Market, 2016 - 2028 (USD Million)
    3. Europe Vaccine Contract Manufacturing Market, by Vaccine Type
      1. By Live Attenuated Vaccines
      2. By Conjugate Vaccines
      3. By Subunit Subunit Vaccines
      4. By Inactivated Vaccines
      5. By Recombinant Vector Vaccines
      6. By Toxoid Vaccines
      7. By Synthetic Vaccines
    4. Europe Vaccine Contract Manufacturing Market, by Service Type
      1. By Fill-Finish
      2. By Bulk Product
    5. Europe Vaccine Contract Manufacturing Market, by Product Type
      1. By Single Vaccine
      2. By Combination Vaccine
    6. Europe Vaccine Contract Manufacturing Market, by Country
      1. Germany
        1. Germany Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. Germany Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. Germany Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      2. UK
        1. UK Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. UK Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. UK Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      3. France
        1. France Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. France Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. France Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      4. Spain
        1. Spain Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. Spain Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. Spain Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      5. Italy
        1. Italy Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. Italy Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. Italy Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      6. BENELUX
        1. BENELUX Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. BENELUX Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. BENELUX Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      7. Rest of Europe
        1. Rest Of Europe Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. Rest Of Europe Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. Rest Of Europe Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
  6. Asia Pacific Vaccine Contract Manufacturing Market - Segment Analysis
    1. Overview
    2. Asia Pacific Vaccine Contract Manufacturing Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Vaccine Contract Manufacturing Market, by Vaccine Type
      1. By Live Attenuated Vaccines
      2. By Conjugate Vaccines
      3. By Subunit Subunit Vaccines
      4. By Inactivated Vaccines
      5. By Recombinant Vector Vaccines
      6. By Toxoid Vaccines
      7. By Synthetic Vaccines
    4. Asia Pacific Vaccine Contract Manufacturing Market, by Service Type
      1. By Fill-Finish
      2. By Bulk Product
    5. Asia Pacific Vaccine Contract Manufacturing Market, by Product Type
      1. By Single Vaccine
      2. By Combination Vaccine
    6. Asia Pacific Vaccine Contract Manufacturing Market, by Country
      1. China
        1. China Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. China Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. China Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      2. Japan
        1. Japan Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. Japan Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. Japan Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      3. India
        1. India Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. India Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. India Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      4. South Korea
        1. South Korea Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. South Korea Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. South Korea Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      5. South East Asia
        1. South East Asia Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. South East Asia Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. South East Asia Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. Rest of Asia Pacific Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. Rest of Asia Pacific Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
  7. Latin America Vaccine Contract Manufacturing Market - Segment Analysis
    1. Overview
    2. Latin America Vaccine Contract Manufacturing Market, 2016 - 2028 (USD Million)
    3. Latin America Vaccine Contract Manufacturing Market, by Vaccine Type
      1. By Live Attenuated Vaccines
      2. By Conjugate Vaccines
      3. By Subunit Subunit Vaccines
      4. By Inactivated Vaccines
      5. By Recombinant Vector Vaccines
      6. By Toxoid Vaccines
      7. By Synthetic Vaccines
    4. Latin America Vaccine Contract Manufacturing Market, by Service Type
      1. By Fill-Finish
      2. By Bulk Product
    5. Latin America Vaccine Contract Manufacturing Market, by Product Type
      1. By Single Vaccine
      2. By Combination Vaccine
    6. Latin America Vaccine Contract Manufacturing Market, by Country
      1. Brazil
        1. Brazil Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. Brazil Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. Brazil Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      2. Argentina
        1. Argentina Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. Argentina Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. Argentina Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      3. Rest of Latin America
        1. Rest of Latin America Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. Rest of Latin America Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. Rest of Latin America Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
  8. Middle East & Africa Vaccine Contract Manufacturing Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Vaccine Contract Manufacturing Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Vaccine Contract Manufacturing Market, by Vaccine Type
      1. By Live Attenuated Vaccines
      2. By Conjugate Vaccines
      3. By Subunit Subunit Vaccines
      4. By Inactivated Vaccines
      5. By Recombinant Vector Vaccines
      6. By Toxoid Vaccines
      7. By Synthetic Vaccines
    4. Middle East & Africa Vaccine Contract Manufacturing Market, by Service Type
      1. By Fill-Finish
      2. By Bulk Product
    5. Middle East & Africa Vaccine Contract Manufacturing Market, by Product Type
      1. By Single Vaccine
      2. By Combination Vaccine
    6. Middle East & Africa Vaccine Contract Manufacturing Market, by Country
      1. GCC Countries
        1. GCC Countries Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. GCC Countries Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. GCC Countries Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      2. South Africa
        1. South Africa Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. South Africa Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. South Africa Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Vaccine Contract Manufacturing Market, By Vaccine Type
          1. By Live Attenuated Vaccines
          2. By Conjugate Vaccines
          3. By Subunit Subunit Vaccines
          4. By Inactivated Vaccines
          5. By Recombinant Vector Vaccines
          6. By Toxoid Vaccines
          7. By Synthetic Vaccines
        2. Rest of Middle East & Africa Vaccine Contract Manufacturing Market, By Service Type
          1. By Fill-Finish
          2. By Bulk Product
        3. Rest of Middle East & Africa Vaccine Contract Manufacturing Market, By Product Type
          1. By Single Vaccine
          2. By Combination Vaccine
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Ajinomoto Co. Inc. (Japan)
    2. Albany Molecular Research Inc. (U.S.)
    3. Catalent Inc. (U.S.)
    4. Cobra Biologics Limited (UK)
    5. Cytovance Biologics Inc. (U.S.)
    6. Fujifilm Holdings Corporation (Japan)
    7. ICON PLC (Ireland)
    8. IDT Biologika GmbH (Germany)
    9. Lonza Group AG (Switzerland)
    10. Merck KGaA (Germany)
    11. Pharmaceutical Product Development LLC (U.S.)
    12. PRA Health Sciences Inc. (U.S.)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 07-Sep-2023
Vaccine Contract Manufacturing Market to Reach Valuation of USD 7.4 Billion by 2030 – Cost-Effectiveness and Flexibility Offered by Contract Manufacturing Drives the Market Growth
FAQ
Frequently Asked Question

  • The global Vaccine Contract Manufacturing valued at USD 3.1 Billion in 2022 and is expected to reach USD 7.4 Billion in 2030 growing at a CAGR of 11.5%.

  • The prominent players in the market are Ajinomoto Co. Inc. (Japan), Albany Molecular Research Inc. (U.S.), Catalent Inc. (U.S.), Cobra Biologics Limited (UK), Cytovance Biologics Inc. (U.S.), Fujifilm Holdings Corporation (Japan), ICON PLC (Ireland), IDT Biologika GmbH (Germany), Lonza Group AG (Switzerland), Merck KGaA (Germany), Pharmaceutical Product Development LLC (U.S.), PRA Health Sciences Inc. (U.S.).

  • The market is project to grow at a CAGR of 11.5% between 2023 and 2030.

  • The driving factors of the Vaccine Contract Manufacturing include

    • Advancements in Technology and Cost Benefits in Infrastructure and Operational Benefits

  • North America was the leading regional segment of the Vaccine Contract Manufacturing in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy